Suppr超能文献

对于引产可能性不佳的患者,前列腺素E2阴道栓剂与宫颈内前列腺素凝胶用于引产的效果比较

The efficiency of prostaglandin E2 vaginal suppositories versus intracervical prostaglandin gel for induction of labor in patients with unfavorable inducibility prospects.

作者信息

Legarth J, Guldbaek E, Scher N J

机构信息

Department of Obstetrics and Gynecology, Copenhagen University Hospital, Hvidovre, Denmark.

出版信息

Eur J Obstet Gynecol Reprod Biol. 1988 Feb;27(2):93-8. doi: 10.1016/0028-2243(88)90001-9.

Abstract

Two different applications of prostaglandin E2 for induction of labor were randomly used in 113 women with an unripe cervix; 57 women were given prostaglandin suppositories each containing 2.5 mg PGE2 in a basis of Witepsol S55 (Dynamit Nobel), another 56 women were treated with intracervical gel containing 1 mg PGE2 in 5 g hydroxypropylmethyl cellulose. The treatment was repeated after 4 h if the cervix was still unripe, and the procedure was repeated the following day if the cervix was still unfavorable. Cesarean sections was performed within 48 h after the start of induction and before the second stage of labor in 8 women in the suppository group and 7 women in the intracervical gel group. Of the remaining 98 women, 73% (34/48 women) in the suppository group and 36% (18/50 women) in the cervical gel group had delivered within 24 h (p less than 0.01). After 48 h, 88% (42/48 women) in the suppository group and 74% of the women (37/50 women) in the cervical gel group had delivered (p greater than 0.05). The induction-delivery interval in the suppository group was half that found in the cervical gel group. There was no significant difference between the two groups in the use of instrumental vaginal deliveries and cesarean sections nor was there any difference with regard to fetal distress. The post-delivery condition of the newborn was similar in the two groups. No side-effects were reported in either of the two groups.

摘要

113名宫颈未成熟的女性被随机采用两种不同的前列腺素E2引产方法;57名女性使用每颗含2.5毫克PGE2的前列腺素栓剂,基质为Witepsol S55(诺贝尔炸药公司),另外56名女性采用含1毫克PGE2的5克羟丙基甲基纤维素宫颈内凝胶治疗。如果宫颈仍未成熟,4小时后重复治疗;如果宫颈条件仍不佳,则于次日重复该操作。栓剂组8名女性和宫颈内凝胶组7名女性在引产开始后48小时内且在第二产程前进行了剖宫产。在其余98名女性中,栓剂组73%(48名女性中的34名)和宫颈凝胶组36%(50名女性中的18名)在24小时内分娩(p小于0.01)。48小时后,栓剂组88%(48名女性中的42名)和宫颈凝胶组74%(50名女性中的37名)分娩(p大于0.05)。栓剂组的引产至分娩间隔时间为宫颈凝胶组的一半。两组在器械助产和剖宫产的使用上无显著差异,胎儿窘迫情况也无差异。两组新生儿产后状况相似。两组均未报告有副作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验